ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Watchlist Price Alert

Precision BioSciences Inc... (DTIL)

NASDAQ: DTIL · Real-Time Price · USD

4.18

-0.12 (-2.79%)

At close: Jun 30, 2025, 3:35 PM

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

DTIL News

5 days ago - Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - businesswire.com
46 days ago - Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - zacks.com
46 days ago - Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update - businesswire.com
47 days ago - Precision BioSciences Accelerates Development of PBGENE-DMD Within its Wholly Owned Organic Pipeline and Highlights Pre-clinical Evidence at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - businesswire.com
53 days ago - Precision BioSciences to Report First Quarter 2025 Results on May 15, 2025 - businesswire.com
54 days ago - Precision BioSciences Announces Presentation of Initial Safety Data from the Phase 1 ELIMINATE-B Trial Evaluating PBGENE-HBV at the 2025 European Association for the Study of the Liver Congress (EASL) - businesswire.com
60 days ago - Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - businesswire.com
62 days ago - Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - businesswire.com
75 days ago - DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - zacks.com
76 days ago - Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B - businesswire.com

Add to Watchlist

✕

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Discord Bot
Free Newsletter
Get Support

Website

Login
FAQ
Sitemap
Learning Center
Affiliate Program

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Imprint

© 2025 Stocknear. All rights reserved.